Patent ID: 8013159

Claim:
A compound according to the following formula: or a pharmaceutically acceptable salt thereof, wherein: A is N, B is CH; Y and Z are CH; Q is C; R 1 and R 2 are independently selected from the group consisting of: C 1-6 alkoxy, C 1-6 fluoroalkoxy, C 3-6 cycloalkoxy, C 3 -6 cycloalkylmethoxy, and C 1 -6 perfluoroalkoxy; R 3 and R 4 are independently selected from the group consisting of: H, halogen, C 1-6 alkyl, C 3 -6 cycloalkyl, C 1-6 fluoroalkyl, C 1-6 alkoxy, C 1-6 fluoroalkoxy, C 3 -6 cycloalkoxy, C 3 -6 cycloalkylmethoxy, NH 2 , —NHC 1-4 alkyl, —N(C 1-4 alkyl) 2 , NO 2 , OH and CN; R 7 to R 10 are H; R 11 is selected from the group consisting of: (a) C 1-6 alkyl, (b) C 3-6 cycloalkyl, (c) C 3-6 cycloalkyl substituted by one to three substituents independently selected from R 12 ; (d) aryl, (e) aryl substituted by one to three substituents independently selected from R 12 , (f) heteroaryl, (g) heteroaryl substituted by one to three substituents independently selected from R 12 , (h) heterocyclyl, (i) heterocyclyl substituted by one to three substituents independently selected from R 12 , (j) —C 1-6 alkylaryl, (k) —C 1-6 alkylaryl substituted by one to five substituents independently selected from R 12 , (k) —C 1-6 alkyl-C 3-6 cycloalkyl; (l) —C 1-6 alkyl-C 3-6 cycloalkyl substituted by one to five substituents independently selected from R 12 ; (m) —C 1-6 alkylhetereoaryl; (n) —C 1 -6 alkylheteroaryl substituted by one to five substituents independently selected from R 12 ; (o) —C 1 -6 alkylheterocyclyl; and (p) —C 1-6 alkylheterocyclyl substituted by one to five substituents independently selected from R 12 ; and fused analogs of (b) to (p); and R 12 is selected from the group consisting of: halogen, C 1-6 alkyl, C 1-6 fluoroalkyl, C 3-6 cycloalkyl, C 1-6 alkoxy, C 1-6 fluoroalkoxy, C 3-6 cycloalkoxy, NH2, —NHC 1-4 alkyl or —N(C 1-4 alkyl) 2 , NO 2 and OH, or two R 12 groups attached to the same atom may be joined together to form a Spiro C 3 -6 cycloalkyl group.